Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 12/20 | 0.48 |
| ▸ | PTGDR | Q13258 | 6/20 | 0.42 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 6/20 | 0.41 |
| ▸ | THRA | P10827 | 4/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12901924 | 0.93 | PTGDR2 (0.42) | PTGDR2PTGDRPTGER2THRBTHRA | |
| SCHEMBL12567856 | 0.91 | PTGDR2 (0.53) | PTGDR2PTGDRPTGER2THRBTHRA | |
| SCHEMBL1276534 | 0.86 | THRB (0.43) | PTGDR2THRBTHRAELANEPTPN1 | |
| SCHEMBL15334636 | 0.84 | THRB (0.41) | PTGDR2THRBTHRAELANEPTPN1 | |
| SCHEMBL12619826 | 0.81 | PTGDR2 (0.41) | PTGDR2PTGDRPTGER2THRBTHRA | |
| SCHEMBL931034 | 0.79 | RXRA (0.44) | PTGDR2THRBTHRA | |
| SCHEMBL12901920 | 0.79 | THRB (0.38) | PTGDR2THRBTHRAELANE | |
| SCHEMBL3902915 | 0.78 | NUDT1 (0.39) | THRBTHRA | |
| SCHEMBL1276108 | 0.78 | ELANE (0.49) | THRBTHRAELANEPTPN1 | |
| SCHEMBL1276580 | 0.77 | THRB (0.40) | PTGDR2PTGER2THRBTHRAELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563770-B2 | Bis(formylphenyl) compound and novel polynuclear polyphenol compound derived from the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-8563770-B2 | Bis(formylphenyl) compound and novel polynuclear polyphenol compound derived from the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20120289735-A1 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-11-15 | — | — | US | disclosed |
| US-20120289735-A1 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-11-15 | — | — | US | disclosed |
| US-20110028752-A1 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20110028752-A1 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028752-A1 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME | PAH, PCBP1, MLLT1 | PTGDR2 4277/4885PTGDR 4522/4885PTGER2 4236/4885 |
| US-20120289735-A1 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME | SLC11A2, PCBP1, NFE2L2 | PTGDR2 2934/4885PTGDR 4168/4885PTGER2 2423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.